Decode Genetics Closing Illinois Facility, Cutting 60 Positions | GenomeWeb

NEW YORK (GenomeWeb News) – Decode Genetics will close its Woodridge, Ill., facility and eliminate around 60 positions, the firm disclosed in a filing with the US Securities and Exchange Commission today.

Decode said that it expects to incur a total of around $1.5 million in cash expenditures connected with the closure of the facility and winding down of operations. Among those costs, it anticipates around $580,000 to be related to employee costs, $150,000 related to chemical disposal costs, $150,000 related to utility costs, and $460,000 related to contract termination fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.